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Abstract
Purpose Evidence regarding whether or not antibiotic
prophylaxis is beneficial in preventing post-operative sur-
gical site infection in adult inguinal hernia repair is con-
flicting. A recent Cochrane review based on 17 randomised
trials did not reach a conclusion on this subject. This study
aimed to describe the current practice and determine
whether clinical equipoise is prevalent.
Methods Surgeons in training were recruited to admin-
ister the Survey of Hernia Antibiotic Prophylaxis usE
survey to consultant-level general surgeons in London and
the south-east of England on their practices and beliefs
regarding antibiotic prophylaxis in adult elective inguinal
hernia repair. Local prophylaxis guidelines for the partic-
ipating hospital sites were also determined.
Results The study was conducted at 34 different sites and
received completed surveys from 229 out of a possible 245
surgeons, a 93 % response rate. Overall, a large majority of
hospital guidelines (22/28) and surgeons’ personal beliefs
(192/229, 84 %) supported the use of single-dose pre-
operative intravenous antibiotic prophylaxis in inguinal
hernia repair, although there was considerable variation in
the regimens in use. The most widely used regimen was
intravenous co-amoxiclav (1.2 g). Less than half of sur-
geons were adherent to their own hospital antibiotic
guidelines for this procedure, although many incorrectly
believed that they were following these.
Conclusion In the south-east of England, there is a strong
majority of surgical opinion in favour of the use of anti-
biotic prophylaxis in this procedure. It is therefore likely to
be extremely difficult to conduct further randomised stud-
ies in the UK to support or refute the effectiveness of
prophylaxis in this commonly performed procedure.
Keywords Antibiotic prophylaxis  Inguinal hernia
repair  Hernioplasty
Introduction
Hernia repair is one of the most commonly performed
general surgical procedures worldwide with an estimated
20 million operations performed annually [1]. Inguinal
hernia repair, either with or without an implanted mesh, is
one of the most frequently performed operations in the UK:
approximately 71,000 primary and recurrent inguinal her-
nia repairs were performed in England in 2010–2011 [2].
Surgical site infection is an important potential compli-
cation of any surgical procedure. In most forms of surgery,
antibiotic prophylaxis is known to reduce the risk of post-
operative wound infection. The relative reduction in risk
appears to be consistently around 60 % across many differ-
ent forms of surgery, ranging from clean to heavily con-
taminated procedures [3]. The ideal timing for optimal serum
drug levels is 30–60 min before surgical incision [4], and
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post-operative administration of antibiotics is now generally
considered to be of no benefit in routine practice [5].
However, there is no clear consensus on whether or not
antibiotic prophylaxis is effective in elective inguinal
hernia repair. Reviewers at the Cochrane Collaboration
concluded in 2012 that evidence derived from 17 ran-
domised controlled trials (RCT) regarding the use of anti-
biotic prophylaxis in inguinal hernia repair both with and
without mesh was inconclusive, neither allowing them to
encourage nor discourage its use [6]. A separate meta-
analysis, also published in 2012, focussed purely on
inguinal hernia repair with mesh and included six of the 11
RCTs identified by the Cochrane review. This analysis
concluded that there was a significant benefit associated
with prophylaxis [7]. One further RCT has recently been
reported: this small study found no significant difference in
risk of infection between use of prophylaxis and placebo
[8]. Drawing from such conflicting evidence, there is
understandable inconsistency between clinical guidelines:
in England and Wales, the National Institute of Clinical
Excellence (NICE) recommend the use of antibiotic pro-
phylaxis in clean surgery with implanted material [9] but
guidelines issued by the Scottish Intercollegiate Guideline
Network (SIGN) state that antibiotic prophylaxis is not
needed in inguinal hernia repair with or without implanted
mesh [10]. The European Hernia Guidelines advise that
there is no indication for routine use of antibiotic prophy-
laxis in elective open or laparoscopic groin hernia repair in
low-risk patients but that prophylaxis should be considered
for patients with risk factors for wound infection [11].
In order to examine the feasibility of a future RCT, this
study aimed to determine policies, practices and beliefs
around the usage of antibiotic prophylaxis in elective
inguinal hernia repair with a mesh in adults and to ascertain
whether clinical equipoise exists regarding the effective-
ness of this treatment. The objective was to survey sur-
geons who routinely perform this procedure in the National
Health Service (NHS) in London and south-east England.
We hypothesised that substantial variation might exist
between hospital policies and individual surgeons’ prac-
tices and that surgeons hold diverse opinions on the effi-
cacy of antibiotic prophylaxis.
Methods
This study was developed and delivered by the London
Surgical Research Group (LSRG), a surgical trainee
research collaborative. The administrative area covered by
the London Deanery (a regional body overseeing the
training of doctors) was used as the reference frame. This
area encompasses all NHS Trusts in London and south-east
England. Trusts and sites that did not perform elective
inguinal hernia repair in adults (e.g. mental health trusts)
were excluded, and we identified the eligible hospitals
within each of the relevant Trusts. Where the same sur-
geons operated in more than one hospital within a Trust,
these were considered as a single site for the purposes of
this survey.
We aimed to achieve the highest possible coverage of all
consultant and associate specialist (consultant-level) gen-
eral surgeons currently performing elective inguinal hernia
repairs within the reference frame. Training-grade surgeons
were recruited as local investigators for the Survey of
Hernia Antibiotic Prophylaxis usE (SHAPE) study in as
many of the eligible hospitals as possible. The principle
institution(s) affiliated with a medical school were cate-
gorised as Teaching Hospitals, all other institutions were
categorised as District General Hospitals (DGH).
All investigators underwent training on the aims and
methods of survey collection. Before surveying com-
menced, investigators submitted details regarding their
own hospital, including the number of eligible consultant/
associate specialist surgeons and the local policy (if any)
regarding use of antibiotic prophylaxis in hernia surgery.
Eligible surgeons were identified by local investigators at
each Trust as they were best placed to determine which
surgeons were actively performing hernia repairs. Each
investigator administered the survey to surgeons in their
hospital only and entered these results into an online
database.
Surgeons of lower levels of seniority, such as specialist
registrars and staff-grade surgeons, were excluded from the
survey as they were considered not to be fully autonomous
in their decision making regarding the use of prophylaxis.
Thus, only consultant-level surgeons who reported that
they had performed elective inguinal hernia repair (either
open or laparoscopic) in adults in the last 12 months in a
NHS hospital were included. Surgeons completing the
survey described the agents, route, timings and duration of
antibiotic prophylaxis they used in elective primary open
and laparoscopic inguinal hernia repair with a mesh in an
idealised 70-kg adult patient with no known allergies or
additional risk factors. Surgeons also reported their beliefs
regarding the effectiveness of antibiotic prophylaxis in
relation to placebo by scoring the likelihood of five state-
ments (e.g. ‘‘Placebo is substantially better than prophy-
laxis’’) on a 10-point scale (1 = very unlikely, 10 = highly
likely)—this approach has previously been used to quantify
the beliefs of doctors regarding the effectiveness of a
treatment [12]. The full survey used in the SHAPE study is
available as ‘‘Appendix 1’’. Wherever a surgeon did not
express a clear preference (e.g. ‘‘I use either A or B’’), this
was evaluated as an even split of preference, such that the
sum of an individual’s responses came to one (e.g.
A = 0.5, B = 0.5).
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Data obtained by this approach were validated by sep-
arately emailing 5 % of surgeons (selected at random from
all respondents) asking them to countercheck their
responses—this approach also permitted comparison of
response rates.
All data were anonymised prior to analysis. Statistical
tests were performed using STATA version 12 (StataCorp,
College Station, Texas, USA). This paper was prepared
according to the STROBE guidelines for reporting of
observational studies [13].
Results
There were 65 eligible hospital sites identified in 44 NHS
Trusts within the London Deanery area. Investigators were
successfully recruited from 35 of these hospital sites, but
one investigator subsequently withdrew without contrib-
uting results so that data were received from 34 sites (four
Teaching Hospitals and 30 DGHs), representing 52 % of
all eligible sites. There was no association between type of
hospital (Teaching Hospital vs. DGH) and inclusion in the
study (Fisher’s exact test p = 0.50). In these 34 hospitals, a
total of 245 eligible surgeons (median 7, range 1–13) were
identified. Surveying was carried out between 1 June and
25 July 2012. A total of 229 completed surveys were
returned, giving an overall response rate of 93 %. Almost
all sites (31/34) achieved a response rate of 80 % or more
(range 25–100 %). Reasons for non-participation included
surgeons declining to complete the survey or the surgeon
being unavailable throughout the study period. The process
of identifying sites and surgeons is shown in Fig. 1.
Amongst the 229 respondents, there were 206 consul-
tants and 23 associate specialists with a median of 9-year
experience (range 0–40 years) since receiving their Cer-
tificate of Completion of Training (CCT) or equivalent. Of
these, 223 (97 %) reported that they performed open repair,
143 (63 %) reported that they performed laparoscopic
repair and 137 (60 %) reported that they performed both.
Of surgeons who completed the survey, 13 were ran-
domly selected to also be contacted by email. Of these,
seven responded and all respondents confirmed that their
survey responses had been reported correctly.
Hospital guidelines for prophylaxis
Out of the 34 hospital sites surveyed, 28 had guidelines in
place applicable to antibiotic prophylaxis in inguinal hernia
repair. Out of these guidelines, 22/28 recommended some
form of single-dose intravenous antibiotic prophylaxis to
be used in inguinal hernia repair with an implanted mesh.
Conversely, 5/28 of these guidelines recommended that
prophylaxis should not be used. One hospital guideline left
the decision about whether or not to use antibiotics for this
procedure to the surgeon. All guidelines advising the use of
antibiotic prophylaxis recommended single-dose intrave-
nous agents, but there was considerable variation in the
preferred drug(s) (Table 1). The most commonly recom-
mended antibiotics were co-amoxiclav 1.2 g (7 guidelines),
cefuroxime 1.5 g (6), and cefuroxime 1.5 g and metroni-
dazole 500 mg (4).
Surgeons’ use of prophylaxis
For open inguinal hernia repair with a mesh, 193/223
(87 %) surgeons reported that they would use antibiotic
prophylaxis; 28/223 (13 %) surgeons stated that they
would not use any antibiotic prophylaxis. For laparoscopic
repairs, the use of antibiotic prophylaxis was slightly less
common: 113/143 (80 %) surgeons reported that they
would use some form of prophylaxis, but this difference
was not statistically significant (v2 = 3.40, p = 0.065).
There was no evidence that whether or not antibiotic pro-
phylaxis was used was associated with level of experience,
in terms of years since CCT (open repairs; 2-tailed
t test = 0.63, p = 0.530). Most surgeons who performed
both open and laparoscopic surgery stated they would use
the same prophylaxis for both procedures (130/137, 95 %).
Drugs selected for use in prophylaxis
All surgeons who made use of antibiotic prophylaxis reported
that they would use single-dose intravenous antibiotics given
shortly prior to incision (Table 2). In open hernia repairs, the
most commonly described regimen was co-amoxiclav 1.2 g,
accounting for 118/223 (53 %) of surgeons’ preferences, with
a further 11 (5 %) of surgeons reporting the use of an alter-
native co-amoxiclav-based regimen. Regimens based around
the use of cefuroxime (n = 43, 19 %), gentamicin and met-
ronidazole (n = 10, 4 %), and flucloxacillin (n = 5.5, 2 %)Fig. 1 SHAPE study flowchart
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accounted for much of the remainder. The distribution of
regimens suggested for use in laparoscopic surgery was
similar to that in open surgery.
A small number of surgeons described use of unusual
intravenous regimens involving agents that are normally
reserved for specialist purposes, such as ertapenem, tazocin
or clindamycin (n = 5.5, 2 %). A very small number of
surgeons reported they would use topical gentamicin
applied to the implanted mesh (n = 3, 1 %), though this
was always in addition to an intravenous agent.
Adherence to local guidelines
In the 27 hospitals where the local guidelines made a
specific recommendation about the use of antibiotic pro-
phylaxis in open inguinal hernia repair, only 86/186 (46 %)
surgeons reported a practice that was adherent to their
own local guidelines. This level of adherence varied
Table 2 Antibiotic prophylaxis agents for use in open and laparoscopic inguinal hernia repair
Antibiotic prophylaxis regimen Open (%) Laparoscopic (%)
No antibiotics 28 (13) 28 (20)
Co-amoxiclav 1.2 g IV 118 (53) 74 (52)
Co-amoxiclav 625 mg IVa 1 (0) 2 (1)
Co-amoxiclav 375 mg IVa 1 (0) 0 (0)
Co-amoxiclav 1.2 g and metronidazole 500 mg IV 2 (1) 2 (1)
Co-amoxiclav 1.2 g and gentamicin 160 mg IV 5 (2) 3 (2)
Co-amoxiclav 1.2 g IV and gentamicin 80 mg applied topically to mesh 2 (1) 1 (1)
Cefuroxime 1.5 g IV 25 (11) 7.5 (5)
Cefuroxime 750 mg IV 9 (4) 5 (3)
Cefuroxime 1.5 g and metronidazole 500 mg IV 6 (3) 1 (1)
Cefuroxime 750 mg and metronidazole 500 mg IV 2 (1) 2 (1)
Cefuroxime 750 mg IV and 80 mg gentamicin applied topically to mesh 1 (0) 0 (0)
Flucloxacillin 1 g IV 1 (0) 1 (1)
Flucloxacillin 500 mg and amoxicillin 500 mg IV 1 (0) 1 (1)
Flucloxacillin 500 mg and gentamicin 120 mg IV 2 (1) 0 (0)
Flucloxacillin 500 mg and gentamicin 80 mg IV 1 (0) 1 (1)
Flucloxacillin 500 mg IV 0.5 (0) 0.5 (0)
Gentamicin 160 mg and amoxicillin 500 mg and metronidazole 500 mg IV 1 (0) 1 (1)
Gentamicin 4 mg/kg and metronidazole 500 mg IV 2 (1) 2 (1)
Gentamicin 3 mg/kg and metronidazole 1 g IV 3 (1) 3 (2)
Gentamicin 120 mg and metronidazole 500 mg IV 1 (0) 1 (1)
Gentamicin 240 mg and metronidazole 500 mg IV 3 (1) 1 (1)
Tazocin 4.5 g IV 0.5 (0) 0 (0)
Ertapenem 1 g IV 4.5 (2) 3.5 (2)
Clindamycin 600 mg IV 0.5 (0) 0.5 (0)
Use prophylaxis but choice of drug unclear 2 (1) 2 (1)
Total 223 (100) 143 (100)
Wherever a surgeon did not express a clear preference (e.g. ‘‘I use either A or B’’), this was evaluated as an even split of preference, such that the
sum of an individual’s responses came to one (e.g. A = 0.5, B = 0.5)
a Preparation does not exist in the British National Formulary (www.bnf.org)—responses are given as reported
Table 1 Hospital guidelines for antibiotic prophylaxis in inguinal
hernia repair with mesh
Recommended regimen Number of
sites
Co-amoxiclav 1.2 g IV 7
Co-amoxiclav 1.2 g IV and gentamicin 160 mg IV 1
Cefuroxime 1.5 g IV 6
Cefuroxime 1.5 g and metronidazole 500 mg IV 4
Cefuroxime 750 mg IV and metronidazole 500 mg IV 1
Gentamicin 240 mg IV and metronidazole 500 mg IV 1
Gentamicin 3 mg/kg and metronidazole 1 g IV 1
Gentamicin 160 mg IV and metronidazole 500 mg IV
and amoxicillin 500 mg IV
1
No antibiotics to be used 5
Guidelines in place with no clear recommendation 1
No guidelines currently in place 6
Total 34
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considerably between hospitals, ranging from none of the
surgeons (in seven hospitals) to all surgeons (in three
hospitals). When surgeons were asked to give the reason
for their reported use of antibiotic prophylaxis, 104 sur-
geons stated that they were following local guidelines.
However, of these, only 56 (54 %) described a practice that
actually adhered to the relevant hospital policy. There was
no evidence that adherence to guidelines was influenced by
level of experience (years since CCT; t test statis-
tic = 0.176, p = 0.860), professional grade (consultant vs.
associate specialist, v2 = 0.146, p = 0.703) or type of
institution (Teaching Hospital vs. DGH, Fisher’s exact test;
p = 0.110).
Surgeons’ beliefs about the effectiveness of antibiotic
prophylaxis
All 229 surgeons quantified their beliefs regarding the
effectiveness of antibiotic prophylaxis by scoring the
likelihood of five separate statements. Figure 2a shows the
mean likelihood score (between 1 and 10) assigned for
each statement; Fig. 2b shows a count for each statement of
how many surgeons believed that this statement was the
most likely to be true. Of the statements, 129/229 (56 %)
surgeons rated the statement ‘‘Prophylaxis is substantially
better than placebo’’ most favourably and a further 63
(28 %) rated ‘‘Prophylaxis is slightly better than placebo’’
as their most-favoured statement. Beliefs and practices
were largely congruent—for 200/229 (87 %) surgeons,
their stated practice conformed to their most strongly held
belief.
Discussion
In this large survey of hospital guidelines and surgeons’
practices and beliefs, we surveyed approximately half of all
trusts and surgeons currently performing inguinal hernia
repairs in the south-east of England. Where hospitals had
guidelines in place, the majority of these (22/28) recom-
mended that antibiotic prophylaxis should be used in
inguinal hernia repair; only a minority (5/28) recom-
mended that prophylaxis was not needed. All guidelines
advocating the use of prophylaxis recommended regi-
mens comprising single-dose intravenous injections given
immediately before first incision.
A large majority of surgeons (87 %) reported they
would use some form of single-dose intravenous pre-
operative antibiotic prophylaxis for elective open inguinal
hernia repair with a mesh in an idealised patient without
allergies or risk factors. A similar proportion (84 %)
believed that prophylaxis was either slightly or substan-
tially better than a placebo (Fig. 2b). A dose of 1.2 g of co-
amoxiclav was the most popular antibiotic choice for both
hospital guidelines and surgeons’ usage, but use of a wide
variety of other drugs was described. The use of non-
standard regimens, such as topical gentamicin applied to
the hernia mesh or intravenous carbapenems, was also
reported, albeit rarely. The use of topical prophylaxis has
recently been reviewed [14] and, although this practice
may be beneficial in some other forms of surgery, it does
not appear to have a role in routine inguinal hernia repair.
The effectiveness of hospital guidelines in influencing
the practice of surgeons regarding the choice of antibiotic
seemed poor: less than half of surgeons were adherent to
their hospital prophylaxis guideline, and furthermore 46 %
of surgeons incorrectly believed that their own practice was
in accordance with their local guidelines. By contrast,
personal beliefs appeared a stronger determinant of prac-
tice—87 % of surgeons had a practice that reflected their
own beliefs about the effectiveness of prophylaxis.
Surveys of guidelines and practices in this area are
important as the evidence base is currently inconclusive.
According to reviewers at the Cochrane Collaboration in
2012, there is no clear indication whether or not antibiotic
prophylaxis is beneficial. In Spain in 1996, a survey found
that antibiotic prophylaxis was recommended in inguinal
Fig. 2 Surgeons’ beliefs on the use of prophylactic antibiotics for
elective inguinal hernia repair (n = 229)
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hernia repair in 50/72 (69 %) hospitals but the authors
noted that they could not determine whether the actual
practices of surgeons followed these guidelines [15]. In
Brazil in 1995–1996, a survey in a single teaching hospital
where the hospital policy stated that no prophylaxis should
be used for inguinal hernia repair found that antibiotics
were given in 20/43 of these operations, often in multiple
doses [16]. We are not aware of any previous studies that
have examined this subject in the UK.
To our knowledge, this is the largest-ever survey that
has simultaneously assessed hospital guidelines and the
practices and beliefs of surgeons regarding the use of
antibiotic prophylaxis in elective inguinal hernia repair in
adults. This survey was undertaken within a clearly defined
reference frame in the UK, with a total of 34 participating
sites and with no indication of differential participation
between DGHs and Teaching Hospitals. This study used an
innovative trainee-led approach to collecting these data.
The use of multiple online tools for investigator training,
survey collection and data analysis facilitated the rapid and
low-cost delivery of the study. We have shown that a
trainee research collaborative can achieve a response rate
beyond that attainable with traditional approaches to sur-
veying. As this study had a 93 % response rate from par-
ticipating sites, there is unlikely to be significant bias
arising from differential non-participation of surgeons. For
comparison, two high-profile surveys of surgeons in the
UK achieved response rates of 71 % (60/85 plastic sur-
geons) [17] and 76 % (376/498 breast surgeons) [18]. We
found that when consultant general surgeons were directly
contacted by email, a relatively poor response rate (54 %)
was obtained—though all respondents indicated that their
survey responses had been correctly reported by the local
investigator. A limitation of this study is that it was con-
fined to surgeons in the south-east of England. There is no
reason to believe that the results of this survey cannot be
generalised within the UK, but as the use of antibiotics
shows considerable variation between countries, these
results may not necessarily reflect practices and opinions
elsewhere. It is also possible that this survey collection
method is subject to interviewer bias or poor reliability but
we believe this risk is minimal as we used a standardised
written questionnaire and trained investigators appropri-
ately prior to data collection.
The results of this survey suggest that research into
the benefit of prophylaxis in inguinal hernia repair has
reached an impasse. The evidence base for antibiotic
prophylaxis in this procedure is inconclusive and further
RCTs are needed. However, clinical equipoise is an
essential prerequisite for any such study. Ethicists have
found that when professional belief of treatment effec-
tiveness is beyond an 80:20 ratio (i.e. 80 % of profes-
sionals hold one belief, 20 % the converse), less than 3 %
of the lay public would consider a RCT of that treatment
morally justifiable [19]. In this survey, 84 % of surgeons
in London and south-east England believed prophylaxis to
be more effective than placebo. It is therefore hard to
conceive of a further RCT on this question being under-
taken in this area or any other location where surgeons
hold similar opinions. In the absence of conclusive evi-
dence, practice will continue to be largely determined by
professional opinion.
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